needed effects
medicines like vincristine
active ingredient
vincasar pfs
unwanted effects
blood problems
nervous system problems
loss of hair
other side effects
others
way
medicines
body
chance
other unwanted effects
months
years after the medicine
possible effects
doctor
vincristine side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
other side effects
medical attention
medicine
temporary loss of hair
treatment with vincristine
treatment
normal hair growth
use of vincristine
active ingredient
vincasar pfs
patients
possibility of untoward symptoms
adverse reactions
use of the drug
dose
nervous system
side effects
sequence
sensory impairment
paresthesia
patients
numbness
pin prick
tingling sensation
treatment
neuritic pain
motor difficulties
loss of deep-tendon reflexes
foot drop
wrist drop
slapping gait
ataxia
paralysis
continued administration
cranial nerve manifestations
including
isolated paresis
paralysis of muscles
cranial nerves
absence of motor impairment
laryngeal muscles
jaw pain
pharyngeal pain
parotid gland pain
bone pain
pain
limb pain
myalgias
pain in these areas
convulsions
hypertension
case of acute fulminant encephalopathy with severe mental confusion
focal seizure
coma
dose-limiting clinical toxicity
neurotoxicity
study
patients
lymphoma
neuropathy
patients with other malignant diseases
symptoms
long term study
effects of vincristine on the peripheral nervous system of patients
cumulative dose of mg
weeks
signs
symptoms of vincristine neuropathy
majority of patients
prognosis
case report of a patient with a familial variant of charcot-marie-tooth syndrome
receiving
mg dosages
weakness
peripheral neuropathy
paraplegia
acute acoustic nerve palsy
dermatologic side effects
alopecia
rash
alopecia
common adverse reaction
soft tissue damage
extravasation
place
acute shortness of breath
severe bronchospasm
vincristine
active ingredient
vincasar pfs
combination with mitomycin
adverse effects
aggressive treatment
preexisting
preexisting pulmonary dysfunction
onset of these reactions
minutes
hours after the administration of vincristine
weeks
dose of mitomycin
respiratory side effects
acute shortness of breath
severe bronchospasm
been reported following
administration of vinca alkaloids
progressive dyspnea
requiring chronic therapy
gastrointestinal side effects
constipation
abdominal cramps
anorexia
weight loss
nausea
vomiting
oral ulceration
diarrhea
paralytic ileus
intestinal necrosis
megacolon
perforation
constipation
form of upper colon impaction
physical examination
rectum
colicky abdominal pain
empty rectum
physician
flat film of the abdomen
demonstrating
condition
cases
high enemas
laxatives
paralytic ileus
temporary discontinuance of the drug
symptomatic care
hematologic side effects
anemia
leukopenia
thrombocytopenia
central-nervous-system leukemia
myelosuppression
drug
significant effect on platelets
red blood cells
cardiovascular
side effects
hypertension
hypotension
patients
received mediastinal radiation
vincristine
active ingredient
vincasar pfs
part of combination chemotherapy
coronary artery disease
myocardial infarction
ocular side effects
transient cortical blindness
diplopia
ptosis
photophobia
optic atrophy with blindness
endocrine side effects
pancreatitis
syndrome
inappropriate antidiuretic hormone
syndrome
high urinary sodium excretion in the presence of hyponatremia
adrenal disease
hypotension
dehydration
azotemia
clinical edema
fluid deprivation
improvement
hyponatremia
renal loss of sodium
treatment with vincristine
genitourinary side effects
polyuria
dysuria
urinary retention
bladder atony
amenorrhea
azoospermia
patients
receiving combination chemotherapy
alkylating agent
procarbazine
prednisone
clinicians
counsel patients
regarding reproductive risks if appropriate
study of males
chemotherapy as children
time of the study
fold increase in azoospermia
patients
vincristine
study
vincristine
unrecognized important role
causing
irreversible azoospermia
childhood
adolescence
studies in rats
mice
evidence of carcinogenesis
oncologic side effects
second malignancies
been reported following
administration of vincristine in combination with chemotherapeutic drugs
known carcinogens
hypersensitivity side effects
anaphylaxis
rash
edema
patients
receiving vincristine
active ingredient
vincasar pfs
part of a multidrug chemotherapeutic regimen
fatal anaphylaxis
administration of intravenous vincristine
hepatic side effects
case of fatal hepatitis
been reported following therapy with irradiation
vincristine
active ingredient
vincasar pfs
case of moderate transient liver function abnormalities
rechallenge with vincristine
other side effects
fever
headache
gynecomastia
visual hallucinations
cases
patients with recent surgical lesions
intravenous vincristine
active ingredient
vincasar pfs
first patient
incision site
second patient
incisional margins
side effects of vincasar pfs
fda
healthcare professional for medical advice
pain
redness at place of injection
black, tarry stools
blood in urine
stools
cough or hoarseness
fever or chills
red spots on skin
unusual bleeding
bruising
double vision
constipation 
difficulty in walking
drooping eyelids
headache
jaw pain
joint pain
side pain
numbness
tingling in fingers
toes
pain in fingers
toes
pain in testicles
stomach cramps
swelling of feet
lower legs
weakness 
agitation
bed-wetting
confusion
convulsions (seizures)
decrease
increase in urination
dizziness
lightheadedness
getting
lying
sitting position
hallucinations
seeing
hearing
feeling things
lack of sweating
loss of appetite
mental depression 
difficult urination
trouble in sleeping
unconsciousness
sores in mouth
lips
bloating
diarrhea
loss of weight
nausea and vomiting
skin rash